home · filing · 0001125345-22-000070
8-K filed May 24, 2022, 7:59 PM ET
ticker MGNX
CIK 0001125345
leadership
confidence high
sentiment neutral
materiality 0.55
MacroGenics appoints William Heiden as Board Chair, replacing Paulo Costa
MACROGENICS INC
William Heiden appointed as non-executive Chair of the Board and director, effective May 22, 2022.
Heiden replaces Paulo Costa, whose term expired at 2022 Annual Meeting on May 19.
Heiden also appointed to Audit Committee; granted option to purchase 36,000 shares at $3.96, vesting monthly over 36 months.
Board now comprises 8 directors, 7 of whom are independent.
Heiden brings 35 years biopharma experience, most recently CEO of AMAG Pharmaceuticals (acquired 2020 for $650M).
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Paulo Costa
Director
Effective 2022-05-19
Successor William K. Heiden
Filed May 24, 2022, 7:59 PM ET
who served in such position until his term as a director expired on May 19, 2022 upon the conclusion of the 2022 Annual Meeting of Stockholders
Appointed
William K. Heiden
Director
Effective 2022-05-22
Filed May 24, 2022, 7:59 PM ET
approved the appointment of William K. Heiden to serve as a director on the Board, effective immediately.
Effective 2022-05-22
Filed May 24, 2022, 7:59 PM ET
Mr. Heiden has been appointed to serve as non-executive Chair of the Board, effective immediately, replacing Mr. Paulo Costa
Departed
Paulo Costa
Chair of the Board
Effective 2022-05-19
Successor William K. Heiden
Filed May 24, 2022, 7:59 PM ET
replacing Mr. Paulo Costa, who served in such position until his term as a director expired on May 19, 2022
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paulo Costa departed as Director at MACROGENICS INC.
Action term expired
Role Director
Exact text from the filing
who served in such position until his term as a director expired on May 19, 2022 upon the conclusion of the 2022 Annual Meeting of Stockholders
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William K. Heiden was appointed as Director at MACROGENICS INC.
Action appointed
Role Director
Exact text from the filing
approved the appointment of William K. Heiden to serve as a director on the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William K. Heiden was appointed as non-executive Chair of the Board at MACROGENICS INC.
Action appointed
Role non-executive Chair of the Board
Exact text from the filing
Mr. Heiden has been appointed to serve as non-executive Chair of the Board, effective immediately, replacing Mr. Paulo Costa
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paulo Costa departed as Chair of the Board at MACROGENICS INC.
Action term expired
Role Chair of the Board
Exact text from the filing
replacing Mr. Paulo Costa, who served in such position until his term as a director expired on May 19, 2022
View on SEC.gov
Source: SEC EDGAR
accession 0001125345-22-000070
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.